Reported 811,745 shares, up 747,353 (1160.6%) from the prior quarter.
Reported value -43.9%; share count 1160.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 41000 |
| 2022-03-31 | 33000 |
| 2022-06-30 | 0 |
| 2022-12-31 | 3 |
| 2023-03-31 | 0 |
| 2023-06-30 | 2096 |
| 2023-09-30 | 0 |
| 2024-03-31 | 400519 |
| 2024-06-30 | 224610 |
| 2024-09-30 | 167663 |
| 2024-12-31 | 44682 |
| 2025-03-31 | 8287 |
| 2025-06-30 | 0 |
| 2025-06-30 | 19389 |
| 2025-09-30 | 8335 |
| 2025-12-31 | 1029 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -334 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 334 | -943 (-73.8%) | < 0.01% | $1,029 | 2026-02-13 | |
| Q3 2025 | Reduced | 1,277 | -887 (-41.0%) | < 0.01% | $8,335 | 2025-11-14 | |
| Q2 2025 | New | 2,164 | +2,164 (0.0%) | < 0.01% | $19,389 | 2025-08-15 | |
| Q2 2025 | Reduced | 0 | -65,619 (-100.0%) | 0 | $0 | 2025-08-15 | |
| Q1 2025 | Reduced | 65,619 | -150,866 (-69.7%) | < 0.01% | $8,287 | 2025-05-15 | |
| Q4 2024 | Reduced | 216,485 | -435,896 (-66.8%) | < 0.01% | $44,682 | 2025-02-14 | |
| Q3 2024 | Reduced | 652,381 | -159,364 (-19.6%) | < 0.01% | $167,663 | 2024-11-14 | |
| Q2 2024 | Added | 811,745 | +747,353 (1160.6%) | < 0.01% | $224,610 | 2024-08-14 | |
| Q1 2024 | New | 64,392 | +64,392 (0.0%) | < 0.01% | $400,519 | 2024-05-15 | |
| Q3 2023 | Reduced | 0 | -510 (-100.0%) | 0 | $0 | 2023-11-15 | |
| Q2 2023 | New | 510 | +510 (0.0%) | < 0.01% | $2,096 | 2023-08-14 | |
| Q1 2023 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2023-05-15 | |
| Q4 2022 | New | 1 | +1 (0.0%) | < 0.01% | $3 | 2023-02-14 | |
| Q2 2022 | Reduced | 0 | -8,085 (-100.0%) | 0 | $0 | 2022-08-15 | |
| Q1 2022 | Reduced | 8,085 | -1,346 (-14.3%) | < 0.01% | $33,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 9,431 | -20,732 (-68.7%) | < 0.01% | $41,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
94 managers reported LYRA THERAPEUTICS INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | Unchanged | 12,757,562 | 0 | 0.09% | $3,533,844 | 17 qtrs |
| CITADEL ADVISORS LLC | Added | 4,772,816 | +433,715 | < 0.01% | $1,320,638 | 8 qtrs |
| BlackRock Inc | Added | 2,829,978 | +2,678,059 | < 0.01% | $783,055 | 17 qtrs |
| Samsara BioCapital LLC | Unchanged | 2,780,261 | 0 | 0.16% | $769,298 | 9 qtrs |
| VANGUARD GROUP INC | Added | 1,730,915 | +249,434 | < 0.01% | $478,944 | 17 qtrs |
| Ikarian Capital LLC | Unchanged | 1,056,829 | 0 | 0.05% | $292,424 | 16 qtrs |
| Rosalind Advisors Inc | Reduced | 1,034,773 | -109,751 | 0.22% | $286,321 | 3 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | New | 985,631 | +985,631 | < 0.01% | $271,000 | 1 qtr |
| MORGAN STANLEY This report | Added | 811,745 | +747,353 | < 0.01% | $224,610 | 2 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 755,095 | +395,664 | < 0.01% | $208,966 | 17 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 811,745
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.